A Study to Evaluate Platelet Rich Plasma to Treat Vulvar Lichen Sclerosus

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 19, 2022

Primary Completion Date

February 1, 2026

Study Completion Date

February 2, 2026

Conditions

Vulvar Lichen Sclerosus

Interventions

BIOLOGICAL

Autologous Platelet-Rich Plasma (PRP)

Two intralesional injections of approximately 5-6mL given approximately 6 weeks apart

OTHER

Sham Procedure

Intralesional needle insertion without any injectate.

Trial Locations (1)

Mayo Clinic in Florida, Jacksonville

All Listed Sponsors

lead

Jennifer R. Arthurs

OTHER